SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028185
Filing Date
2021-05-17
Accepted
2021-05-17 07:43:13
Documents
85
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acet-10q_20210331.htm   iXBRL 10-Q 2590195
2 EX-31.1 acet-ex311_108.htm EX-31.1 21120
3 EX-31.2 acet-ex312_107.htm EX-31.2 21124
4 EX-32.1 acet-ex321_109.htm EX-32.1 8047
  Complete submission text file 0001564590-21-028185.txt   9605600

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acet-20210331.xsd EX-101.SCH 70861
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acet-20210331_cal.xml EX-101.CAL 52346
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acet-20210331_def.xml EX-101.DEF 215725
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20210331_lab.xml EX-101.LAB 497978
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20210331_pre.xml EX-101.PRE 390877
10 EXTRACTED XBRL INSTANCE DOCUMENT acet-10q_20210331_htm.xml XML 1861182
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 21927596
SIC: 2834 Pharmaceutical Preparations